DocGo Inc. (NASDAQ:DCGO) Stock Has Consensus Target Price of $2.38 According to Analysts

DocGo Inc. (NASDAQ:DCGO) has earned a consensus recommendation of “Hold” from the six analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $2.38.

Several analysts have weighed in on the stock. Canaccord Genuity Group reissued a “hold” rating and issued a $1.00 price target on shares of DocGo in a research note on Tuesday, August 18th. Needham & Company LLC reaffirmed a “buy” rating on shares of DocGo in a research note on Wednesday, September 30th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a research note on Monday, September 14th.

Institutional Investors Weigh In On DocGo

Institutional investors have recently bought and sold shares of the stock. Empowered Funds LLC purchased a new position in DocGo during the second quarter valued at $79,000. S Squared Technology LLC bought a new stake in DocGo in the second quarter worth $1,060,725. Ieq Capital LLC purchased a new stake in shares of DocGo in the second quarter worth $126,000. Diversify Advisory Services LLC purchased a new stake in shares of DocGo in the second quarter worth $53,000. Finally, BlackRock Inc. purchased a new stake in shares of DocGo in the second quarter worth $750,000. 56.44% of the stock is currently owned by hedge funds and other institutional investors.

DocGo Price Performance

DCGO stock opened at $0.27 on Wednesday. DocGo has a one year low of $0.24 and a one year high of $1.27. The company’s 50 day moving average price is $0.37 and its two-hundred day moving average price is $0.52.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings data on Monday, August 17th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.06). DocGo had a negative net margin of 65.29% and a negative return on equity of 40.42%. The business had revenue of $73.42 million during the quarter, compared to analysts’ expectations of $75.35 million. As a group, analysts anticipate that DocGo will post -0.22 earnings per share for the current year.

About DocGo

DocGo Inc (NASDAQ: DCGO) is a healthcare technology and services company that delivers medical care and patient-support services outside traditional healthcare facilities. Its platform combines mobile medical teams, technology, logistics and data-driven care coordination to help healthcare providers, government agencies and other organizations reach patients in their homes, workplaces and communities.

The company’s services have included mobile health services, non-emergency medical transportation, remote patient monitoring, community-based clinical care, COVID-19 testing and vaccination programs, and assistance with patient engagement and care navigation.